Skip to main content
. 2019 Jul 25;18(3):2877–2884. doi: 10.3892/ol.2019.10665

Figure 3.

Figure 3.

Upregulated SPINK2 is associated with the poor prognosis of patients with acute myeloid leukemia. (A) In the GEPIA dataset, patients with high SPINK2 expression had poor outcomes (hazard ratio=2.3, P=0.0039). (B) In the UALCAN dataset, patients with high SPINK2 expression would have shorter survival time than those with lower SPINK2 levels (P=0.024). SPINK2, serine protease inhibitor Kazal-type 2; GEPIA, gene expression profiling interactive analysis.